After several months of silence due to the mandatory shutdown in place, the training division of Global Stem Cells Group --known as ISSCA Training-- has officially announced the reopening of its regularly scheduled training dates Around the world
(PRUnderground) May 20th, 2020
“The future’s looking bright for our Regenerative MedicineTraining program, we’ve taken our course and updated it, reinforcing it with new information and quality protocols that’ll help doctors and their patients manage this ‘new normal’ as well as they can, and we’re very excited to be able to be bringing this new information to physicians around the world– but we’ve decided to start small for now, with the reinstatement of our headquarters’ operations,” — Benito Novas, CEO
Because of the growing interest in the industry , ISSCA Regenerative MedicineTraining has updated its program with new protocols focused on the optimization of the body at the cellular level. Notably, their upcoming June course will also include live practice patients in the treatments of autologous cell therapy, which includes PRP, adipose-derived stem cells, bone-marrow derived stem cells, exosomes, Umbilical Cord Blood Cells, and other novel techniques.
Stem Cell Training is a company that seeks to instruct medical professionals around the world on regenerative medicine techniques. They do this by sharing breakthrough scientific research on stem cell therapy and treatment, as well as developing and offering courses, seminars, and workshops based on this research.
About the Global Stem Cells Group:
Global Stem Cells Group is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2010, the company combines dedicated researchers, physicians ,patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge Regenerative Medicine treatments.
With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.
Global Stem Cells Groups corporate mission is to make the promise of Regenerative medicine a reality for patients around the world. With each of GSCGs six operating companies focused on a separate research-based mission, the result is a global network of state-of-the-art regenerative technology
About Global Stem Cells Group
Global Stem Cells Group (GSCG) is a worldwide network that combines seven major medical corporations, each focused on furthering scientific and technological advancements to lead cutting-edge stem cell development, treatments, and training. The united efforts of GSCG’s affiliate companies provide medical practitioners with a one-stop hub for stem cell solutions that adhere to the highest medical standards.Press Contact
Original Press Release.